4.1 USD
+0.35 (+9.33%)
4.1 USD
0 (0%)
Overall SBC gets a fundamental rating of 5 out of 10. We evaluated SBC against 100 industry peers in the Health Care Providers & Services industry. SBC has an excellent financial health rating, but there are some minor concerns on its profitability. SBC is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year SBC was profitable.
SBC had a negative operating cash flow in the past year.
1.2 Ratios
SBC has a Return On Assets of 13.48%. This is amongst the best in the industry. SBC outperforms 98.00% of its industry peers.
SBC's Return On Equity of 17.47% is amongst the best of the industry. SBC outperforms 84.00% of its industry peers.
SBC has a Return On Invested Capital of 21.24%. This is amongst the best in the industry. SBC outperforms 93.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.48% | ||
| ROE | 17.47% | ||
| ROIC | 21.24% |
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SBC's Profit Margin of 24.28% is amongst the best of the industry. SBC outperforms 100.00% of its industry peers.
The Operating Margin of SBC (41.70%) is better than 100.00% of its industry peers.
The Gross Margin of SBC (74.09%) is better than 89.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 41.7% | ||
| PM (TTM) | 24.28% | ||
| GM | 74.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for SBC has been reduced compared to 1 year ago.
The debt/assets ratio for SBC has been reduced compared to a year ago.
2.2 Solvency
SBC has an Altman-Z score of 6.13. This indicates that SBC is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.13, SBC belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
SBC has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
SBC's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. SBC outperforms 77.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.13 |
ROIC/WACC2.47
WACC8.59%
2.3 Liquidity
SBC has a Current Ratio of 5.10. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.10, SBC belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
A Quick Ratio of 5.06 indicates that SBC has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.06, SBC belongs to the best of the industry, outperforming 94.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.1 | ||
| Quick Ratio | 5.06 |
3. Growth
3.1 Past
SBC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.69%, which is quite impressive.
Looking at the last year, SBC shows a quite strong growth in Revenue. The Revenue has grown by 10.85% in the last year.
EPS 1Y (TTM)48.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)10.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.33%
3.2 Future
SBC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.28% yearly.
Based on estimates for the next years, SBC will show a decrease in Revenue. The Revenue will decrease by -0.61% on average per year.
EPS Next Y-26.89%
EPS Next 2Y-8.33%
EPS Next 3Y-0.28%
EPS Next 5YN/A
Revenue Next Year-17.44%
Revenue Next 2Y-6.07%
Revenue Next 3Y-0.61%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.59, the valuation of SBC can be described as very cheap.
Based on the Price/Earnings ratio, SBC is valued cheaper than 96.00% of the companies in the same industry.
SBC is valuated cheaply when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.12 indicates a reasonable valuation of SBC.
SBC's Price/Forward Earnings ratio is rather cheap when compared to the industry. SBC is cheaper than 96.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, SBC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.59 | ||
| Fwd PE | 8.12 |
4.2 Price Multiples
96.00% of the companies in the same industry are more expensive than SBC, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.62 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.33%
EPS Next 3Y-0.28%
5. Dividend
5.1 Amount
No dividends for SBC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.1
+0.35 (+9.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.83%
Inst Owner ChangeN/A
Ins Owners90.38%
Ins Owner Change0%
Market Cap420.58M
Revenue(TTM)178.46M
Net Income(TTM)43.32M
Analysts80
Price Target8.33 (103.17%)
Short Float %1.15%
Short Ratio2.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.66%
Min EPS beat(2)-85.33%
Max EPS beat(2)8.01%
EPS beat(4)3
Avg EPS beat(4)5.59%
Min EPS beat(4)-85.33%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.07%
Min Revenue beat(2)-4.16%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.96%
Min Revenue beat(4)-22.64%
Max Revenue beat(4)-3.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.38%
PT rev (3m)25.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.69%
EPS NY rev (1m)0.39%
EPS NY rev (3m)-1.14%
Revenue NQ rev (1m)-1.3%
Revenue NQ rev (3m)-3.82%
Revenue NY rev (1m)-1.13%
Revenue NY rev (3m)-2.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.59 | ||
| Fwd PE | 8.12 | ||
| P/S | 2.36 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.7 | ||
| P/tB | 1.91 | ||
| EV/EBITDA | 3.62 |
EPS(TTM)0.54
EY13.17%
EPS(NY)0.51
Fwd EY12.32%
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.74
BVpS2.42
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.48% | ||
| ROE | 17.47% | ||
| ROCE | 26.89% | ||
| ROIC | 21.24% | ||
| ROICexc | 39.36% | ||
| ROICexgc | 48.54% | ||
| OM | 41.7% | ||
| PM (TTM) | 24.28% | ||
| GM | 74.09% | ||
| FCFM | N/A |
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.24 | ||
| Cap/Depr | 69.08% | ||
| Cap/Sales | 1.14% | ||
| Interest Coverage | 636.56 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.1 | ||
| Quick Ratio | 5.06 | ||
| Altman-Z | 6.13 |
F-Score5
WACC8.59%
ROIC/WACC2.47
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y-26.89%
EPS Next 2Y-8.33%
EPS Next 3Y-0.28%
EPS Next 5YN/A
Revenue 1Y (TTM)10.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.33%
Revenue Next Year-17.44%
Revenue Next 2Y-6.07%
Revenue Next 3Y-0.61%
Revenue Next 5YN/A
EBIT growth 1Y14.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1928.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1816.19%
OCF growth 3YN/A
OCF growth 5YN/A
SBC MEDICAL GROUP HOLDINGS I / SBC FAQ
What is the fundamental rating for SBC stock?
ChartMill assigns a fundamental rating of 5 / 10 to SBC.
What is the valuation status for SBC stock?
ChartMill assigns a valuation rating of 5 / 10 to SBC MEDICAL GROUP HOLDINGS I (SBC). This can be considered as Fairly Valued.
How profitable is SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
SBC MEDICAL GROUP HOLDINGS I (SBC) has a profitability rating of 5 / 10.
Can you provide the financial health for SBC stock?
The financial health rating of SBC MEDICAL GROUP HOLDINGS I (SBC) is 7 / 10.
What is the expected EPS growth for SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
The Earnings per Share (EPS) of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -26.89% in the next year.